The Use of Hyaluronic Acid in the Non-Surgical Treatment of Periodontitis—An Umbrella Review
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(4), P. 998 - 998
Published: April 20, 2025
Background:
Periodontitis
is
a
prevalent
inflammatory
condition
that
destroys
periodontal
tissues.
Scaling
and
root
planing
(SRP)
the
gold
standard
for
non-surgical
treatment;
however,
its
efficacy
may
be
limited
in
cases
with
complex
dental
issues.
This
umbrella
review
aims
to
evaluate
effectiveness
of
hyaluronic
acid
(HA)
as
an
adjunct
scaling
enhancing
clinical
outcomes
periodontitis
management.
Methods:
A
comprehensive
five
systematic
reviews,
including
meta-analyses
where
available,
was
conducted
synthesize
evidence
on
adjunctive
use
HA
SRP.
The
studies
were
evaluated
using
AMSTAR-2
quality
assessment
tool
determine
methodological
rigor.
Data
parameters
such
probing
depth
(PD),
attachment
level
(CAL),
bleeding
(BOP),
gingival
index
(GI),
plaque
(PI)
extracted
analyzed.
Results:
findings
indicate
supplementation
leads
moderate
improvements
PD,
CAL,
BOP,
GI,
PI
compared
SRP
alone.
Notable
reductions
PD
gains
CAL
observed,
some
showing
statistically
significant
benefits.
However,
heterogeneity
concentrations
(0.2–1.4%),
application
methods,
treatment
frequencies,
follow-up
durations
(1
week
12
months)
limits
definitive
conclusions.
Additionally,
did
not
significantly
affect
reduction
P.
gingivalis
prevalence.
Conclusions:
conjunction
shows
promise
therapy.
methodologies
indicates
necessity
high-quality,
standardized
randomized
controlled
trials
establish
clear
guidelines
periodontitis.
Language: Английский
Comparative Evaluation of Platelet-Rich Fibrin (PRF) and Concentrated Growth Factor (CGF) as Carriers for Antibiotics—In Vitro Study
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(9), P. 4303 - 4303
Published: May 1, 2025
The
rising
prevalence
of
antibiotic
resistance
underscores
the
need
for
localized
drug
delivery
systems
that
minimize
systemic
exposure.
Autologous
platelet
concentrates
(APCs),
including
concentrated
platelet-rich
fibrin
(c-PRF)
and
liquid-phase
growth
factors
(LPCGFs),
have
emerged
as
potential
carriers
antimicrobial
agents.
This
study
aimed
to
evaluate
efficacy
c-PRF
LPCGF
three
formulations-amoxicillin
with
clavulanic
acid,
clindamycin,
a
combination
amoxicillin
metronidazole-against
methicillin-sensitive
Staphylococcus
aureus
(MSSA),
methicillin-resistant
(MRSA),
Enterococcus
faecalis
(low-level
natural
resistance).
disk
diffusion
method
was
employed
incorporate
antibiotics
into
both
APC
types,
which
were
then
applied
disks
placed
on
bacterial
cultures.
size
inhibition
zones
measured
at
20-,
40-,
60-,
80-h
intervals.
Every
20
h,
transferred
new
Petri
dish.
Statistical
analysis
included
Welch's
t-test
two-way
ANOVA.
demonstrated
superior
performance
carrier
showing
presence
up
60
h.
In
contrast,
exhibited
greater
when
used
amoxicillin-metronidazole
combination,
particularly
higher
concentrations.
Both
APCs
showed
limited
effectiveness
against
E.
combined
clindamycin.
confirms
suitability
autologous
systems.
choice
between
should
be
guided
by
drug's
physicochemical
properties
clinical
application.
offer
promising
alternative
targeted
therapy
in
dental
surgical
settings.
Language: Английский
PRF and PRP in Dentistry: An Umbrella Review
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(9), P. 3224 - 3224
Published: May 6, 2025
Introduction:
Platelet-rich
fibrin
(PRF)
and
platelet-rich
plasma
(PRP)
utilize
autologous
blood
share
the
objective
of
leveraging
blood-derived
growth
factors
to
enhance
body’s
natural
healing
process.
A
large
extensive
use
has
been
made
in
various
branches
dentistry.
Methods:
total
4175
records
were
identified
from
electronic
search,
specifically
291
BioMed
Central,
3406
MEDLINE/PubMed,
304
Cochrane
library
databases,
174
PROSPERO
register.
This
review
was
performed
relation
PRISMA
flow
chart
annotated
Results:
In
total,
3416
title
abstracts
screened,
a
40
systematic
reviews
finally
included
present
umbrella
review.
Conclusions:
Research
supports
PRF
PRP
different
fields
is
huge
potential
for
patient
but
also
doctor
as
these
products
are
have
zero
cost.
However,
further
studies
needed,
especially
RCTs,
clearer
evidence
on
role
PRP.
Language: Английский